Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.
Principal Investigator: Dr. Eric Knoche
Study Coordinator: Linda Schimmoeller
This study is currently enrolling patients. To learn more about Talapro and how you can join contact our research office at (314) 289-7690
This study is funded by the Foundation through Pfizer
Principal Investigator: Dr. Eric Knoche
Study Coordinator: Linda Schimmoeller
This study is currently enrolling patients. To learn more about Talapro and how you can join contact our research office at (314) 289-7690
This study is funded by the Foundation through Pfizer